4.2 Article

Effect of obesity on clinical presentation and response to treatment in asthma

期刊

JOURNAL OF ASTHMA
卷 43, 期 7, 页码 553-558

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/02770900600859123

关键词

asthma; obesity; spirometry; theophylline; gastroesophageal reflux disease

资金

  1. NCRR NIH HHS [K23 RR019965] Funding Source: Medline

向作者/读者索取更多资源

Obesity is a risk factor for being diagnosed with asthma, but there is conflicting evidence on whether obesity is a risk factor for lung function abnormalities characteristic of asthma. We studied a cohort of 488 subjects, 47% of whom were obese. Obese and non-obese subjects with asthma had similar airflow limitation and bronchodilator responsiveness, but obese participants had increased sleep disturbance and gastroesophageal reflux disease, higher cytokine levels, and a trend towards increased exacerbations when treated with theophylline. Obese and non-obese asthmatics have similar lung function abnormalities, but comorbidities and altered responses to medications may significantly affect asthma control in obese people.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据